Skip to Main Content

Paper Details

The evolution of patient-specific precision biomarkers to guide personalized heart-transplant care.
Expert Rev Precis Med Drug Dev
6
2021
Genome Project, Human, acute cellular rejection, cardiac allograft injury, cardiac allograft rejection, donor, donor-derived cell-free DNA, leukocyte, leukocyte gene, myocardial, patient
Author NameAffiliation
Mario C DengDavid Geffen School of Medicine at university of california los angeles, Ronald Reagan university of california los angeles Medical Center
Mario C DengDavid Geffen School of Medicine at university of california los angeles, Ronald Reagan university of california los angeles Medical Center
  • 1 - 2

Datasets